Association of High miR-182 Levels with Low-Risk Prostate Cancer

scientific article published on 29 January 2019

Association of High miR-182 Levels with Low-Risk Prostate Cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.AJPATH.2018.12.014
P932PMC publication ID6446228
P698PubMed publication ID30703341

P50authorBethany C BaumannQ59696057
Andrés Martin AcostaQ85570348
P2093author name stringPeter H Gann
Ryan Deaton
Larisa Nonn
Andre Kajdacsy-Balla
Adam Murphy
Anastasiya Sapatynska
Zachary Richards
P2860cites workThe role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasisQ21093318
Identification of novel AR-targeted microRNAs mediating androgen signalling through critical pathways to regulate cell viability in prostate cancerQ21133676
KEGG: kyoto encyclopedia of genes and genomesQ24515297
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profilesQ24536351
The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomyQ24596735
MicroRNA targeting specificity in mammals: determinants beyond seed pairingQ24607724
A microRNA code for prostate cancer metastasisQ27310006
Widespread changes in protein synthesis induced by microRNAsQ27860886
MicroRNA expression profiles classify human cancersQ28032481
Elevated serum microRNA levels associate with absence of high-grade prostate cancer in a retrospective cohortQ28546311
affy--analysis of Affymetrix GeneChip data at the probe levelQ29547353
Practical aspects of planning, building, and interpreting tissue microarrays: the Cooperative Prostate Cancer Tissue Resource experienceQ30483391
Screening of Differently Expressed miRNA and mRNA in Prostate Cancer by Integrated Analysis of Transcription DataQ31096158
The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studiesQ47669687
Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasiaQ47701028
MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met geneQ47756363
A CREB3-regulated ER-Golgi trafficking signature promotes metastatic progression in breast cancer.Q48104459
MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathwayQ49899764
Androgen receptor regulated microRNA miR-182-5p promotes prostate cancer progression by targeting the ARRDC3/ITGB4 pathway.Q50518114
African-American Prostate Cancer Disparities.Q51807661
The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy.Q52744062
Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy.Q54223185
Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic processQ33281964
Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trialQ33575062
Subcellular localization of p27 and prostate cancer recurrence: automated digital microscopy analysis of tissue microarraysQ33811487
Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomyQ33834711
miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cellsQ34064071
Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer.Q34276111
Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific deathQ34424612
Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancerQ34489344
A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancerQ34524380
MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancerQ34576641
The Molecular Taxonomy of Primary Prostate CancerQ34674332
Overexpressed microRNA-182 promotes proliferation and invasion in prostate cancer PC-3 cells by down-regulating N-myc downstream regulated gene 1 (NDRG1).Q34852248
miRDB: an online resource for microRNA target prediction and functional annotationsQ35253629
α-Methylacyl-CoA racemase expression and lethal prostate cancer in the Physicians' Health Study and Health Professionals Follow-up StudyQ35703906
Prostatic compensation of the vitamin D axis in African American men.Q36264367
Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapyQ36945088
Local microRNA delivery targets Palladin and prevents metastatic breast cancer.Q37273646
The importance of protein kinase A in prostate cancer: relationship to patient outcome in Radiation Therapy Oncology Group trial 92-02.Q37389907
A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate CancerQ38281341
Genes associated with prostate cancer are differentially expressed in African American and European American men.Q38397675
Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic ReviewQ38652845
The Potential of MicroRNAs as Prostate Cancer Biomarkers.Q38710305
MiR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cellsQ39203769
Vorinostat and bortezomib synergistically cause ubiquitinated protein accumulation in prostate cancer cellsQ39255092
Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparitiesQ39972544
The miR-183 family cluster alters zinc homeostasis in benign prostate cells, organoids and prostate cancer xenografts.Q41331870
Epithelial and stromal expression of miRNAs during prostate cancer progressionQ42121289
Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significanceQ42501522
Prognostic utility of cell cycle progression score in men with prostate cancer after primary external beam radiation therapyQ43093212
MiR-182 Is Associated with Growth, Migration and Invasion in Prostate Cancer via Suppression of FOXO1.Q43178497
Prostate cancer outcome and tissue levels of metal ionsQ43887535
Tumor immunobiological differences in prostate cancer between African-American and European-American men.Q44513168
DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactionsQ46258111
A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer.Q46331253
A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.Q46658469
Combinations of elevated tissue miRNA-17-92 cluster expression and serum prostate-specific antigen as potential diagnostic biomarkers for prostate cancerQ47110388
Cancer statistics, 2018.Q47191906
Down-regulation of microRNA-182 and microRNA-183 predicts progression of osteosarcomaQ47338569
NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.Q47621362
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)911-923
P577publication date2019-01-29
P1433published inThe American Journal of PathologyQ4744259
P1476titleAssociation of High miR-182 Levels with Low-Risk Prostate Cancer
P478volume189

Reverse relations

cites work (P2860)
Q97538955Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness
Q90657651Role of miRNA-182 and miRNA-187 as potential biomarkers in prostate cancer and its correlation with the staging of prostate cancer

Search more.